Gil Price

Gil Price, M.D. has extensive experience in leadership and governance within the biotechnology and pharmaceutical sectors. Currently serving on the Board of Directors for AssayQuant Technologies Inc., Antisense Therapeutics Ltd. (where also holds the position of Audit Chair), and The Center for Advancing Innovation Inc., Gil Price previously held the roles of President and Chief Executive Officer at NeuroBo Pharmaceuticals, Inc., and Chief Medical Consultant at ProPharma Group. From February 1998 to June 2017, Gil Price was the President and CEO of Drug Safety Solutions, Inc., demonstrating a strong background in executive management and strategic oversight in the industry.